We first performed an in vitro T‐cell killing assay, pretreating myeloma cells with chemotherapy, or PD‐L1 antibodies in different sequences, followed by co‐culture with activated T cells (Figure 7A). This evidence concerns the gene CD274 and plasma cell myeloma.